从Heliopsis longipes根源的乙醇提取物中获得的自我微乳化系统的抗高血压效果在自发性和L-NAME诱导的高血压大鼠中
Dailenys Marrero-Morfa1, Beatriz A Luz-Martínez1, Francisco J Luna-Vázquez2
1Posgrado en Ciencias Químico Biológicas, Facultad de Química, Universidad Autónoma de Querétaro, Querétaro 76010, Mexico.
Molecules (Basel, Switzerland)
|September 27, 2025
概括
来自Heliopsis longipes根的新型药物输送系统 (HL-SMDS) 能够有效降低高血压大鼠的血压. 这种植物药物配方增强了口服生物可用性,改善了内皮功能,提供了有前途的高血压治疗方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
- 心血管研究研究心血管研究
背景情况:
- 动脉高血压是导致心血管疾病的全球主要原因.
- 长 (Heliopsis longipes) 根提取物及其化合物阿芬因显示出抗高血压作用.
- H. longipes 提取物的水溶性较差限制了口服.
研究的目的:
- 开发一种自我微乳化药物递送系统 (HL-SMDS) 用于H. longipes乙醇提取物.
- 在大鼠模型中评估HL-SMDS的抗高血压疗效和内皮作用.
- 评估HL-SMDS在改善口服生物可用性和治疗结果方面的潜力.
主要方法:
- 从H. longipes乙醇提取物开发一种自微乳化药物输送系统 (HL-SMDS).
- 向自发高血压和L-NAME诱导的高血压大鼠给予HL-SMDS.
- 评估系统性血压降低和ex vivo大动脉内皮功能.
主要成果:
- 在两种高血压大鼠模型中,HL-SMDS显著降低了缩血压.
- 与原始提取物相比,HL-SMDS显示出更高的抗高血压疗效.
- 在接受HL-SMDS.SMDS的L-NAME治疗的老鼠的大动脉中观察到增强的内皮功能.
结论:
- HL-SMDS有效地提高了H. longipes提取物的水溶性和口服生物可用性.
- HL-SMDS为高血压管理提供了一个有前途的基于脂质的植物药物配方.
- 这种方法支持开发用于治疗动脉高血压的新型植物药物.
相关概念视频
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
441
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
441
01:23Antihypertensive Drugs: Vasodilators
2.0K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.0K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
936
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
936
01:29Hypertension II: Pathophysiology
795
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
795
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K